SESSION TITLE: Cystic Fibrosis
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: Cystic fibrosis (CF) is a multi-system genetic disorder that affects approximately 30,000 people in the United States. The management of CF has dramatically advanced over the past decades and these patients are now living longer than ever. However, the natural history of the disease continues to be punctuated by periods of exacerbation necessitating prolonged inpatient admissions for treatment with intravenous antibiotics and aggressive respiratory therapy. There is currently a gap in the literature regarding the incidence of deep venous thrombosis (DVT) and venous thromboembolism (VTE) in these patients leading to an uncertainty in the practice of prophylaxis.